Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck's Protease Inhibitor Franchise Growth Tied To MK-994A Combination

Dec 20 1999

• By The Pink Sheet

Related Content

Merck Maintains Merger-Free Philosophy; Co-Promotions Also Ruled Out

Dec 13 1999

Merck Revenue Boost From Astra Deal Restructuring Is About $680 Mil.

Feb 01 1999

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window